The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Relationship to insulin resistance of the adult treatment panel III diagnostic criteria for identification of the metabolic syndrome.
Open accessAbstract
The Adult Treatment Panel III (ATP III) has published criteria for diagnosing the metabolic syndrome, a cluster of closely related abnormalities related to insulin resistance that increase cardiovascular disease risk. The present analysis was performed to evaluate the ability of these criteria to identify insulin-resistant individuals. The population consisted of 443 healthy volunteers, with measurements of BMI, blood pressure, fasting plasma glucose, triglycerides, HDL cholesterol concentrations, and steady-state plasma glucose (SSPG) concentration. Insulin resistance was defined as being in the top tertile of SSPG concentrations. Of the population, 20% satisfied ATP III criteria for the metabolic syndrome. Although insulin resistance and the presence of the metabolic syndrome were significantly associated (P < 0.001), the sensitivity and positive predictive value equaled 46% (69 of 149) and 76% (69 of 91), respectively. Being overweight, with high triglycerides, low HDL cholesterol, or elevated blood pressure, most often resulted in a diagnosis of the metabolic syndrome. Thus, the ATP III criteria do not provide a sensitive approach to identifying insulin-resistant individuals. The individual components vary both in terms of their utility in making a diagnosis of the metabolic syndrome and their relationship to insulin resistance, with the obesity and lipid criteria being most useful.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although insulin resistance is associated with high triglycerides, VLDL and triglyceride concentrations can be similar in patients with widely divergent insulin sensitivity (68, 69).”
From Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline (2012) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Self-citationReport of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2002) · Diabetes Care · doi:10.2337/diacare.25.2007.s5 · Cited by 10,325
Ford, E. S., Giles, W. H., & Dietz, W. H. (2002) · JAMA · doi:10.1001/jama.287.3.356 · Cited by 6,698
Self-citationThe metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Banting lecture 1988. Role of insulin resistance in human disease.
Reaven, G. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,801
Self-citationFollow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis
Dunaif, A. E. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,776
Cited by
Sorted by citations
Items 201–300 of 310
Diabetes and glucose disturbances in patients with psychosis in Sweden
Olsson, E., Westman, J., Hukic, D. S., Eriksson, S. V., Edman, G., Bodén, R., Jedenius, E., Reutfors, J., Berntsson, A., Hilding, A., et al. (2015) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2015-000120 · Cited by 8
Parámetros antropométricos asociados al riesgo cardiovascular en España. Estudio DORICA
Millán, J., Mantilla, T., Bartrina, J. A., Foz, M., Gil, B., Jover, E., Monereo, S., Moreno, B., & Pérez, C. (2007) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(07)74175-x · Cited by 8
[The metabolic syndrome: a cluster of vascular risk factors].
Olijhoek, J. K., Martens, F. M. A. C., Banga, J. D., & Visseren, F. L. J. (2005) · PubMed · Cited by 8
Chanda, H., Kelly, P. J., Andrews, B. S., Siziya, S., & Lakhi, S. (2010) · Medical Journal of Zambia · Cited by 6
Diagnóstico de síndrome metabólico. Adecuación de los criterios diagnósticos en nuestro medio
Ascaso, J. F., González‐Santos, P., Hernández‐Mijares, A., Mangas, A., Masana, L., Millán, J., Pallardo, L. F., Pedro‐Botet, J., Pérez‐Jiménez, F., Pintó, X., et al. (2006) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(06)73697-x · Cited by 9
La cintura hipertrigliceridémica
Ascaso, J. F. (2005) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(05)73357-x · Cited by 8
How to Manage Metabolic Syndrome
Ferrucci, A., Sciarretta, S., Valenti, V., & Tocci, G. (2005) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200512040-00005 · Cited by 7
Cardiometabolic Risk Among African American Women
Appel, S. J., Oster, R. A., Floyd, N. A., & Ovalle, F. (2009) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0b013e318197aa3a · Cited by 7
Controversies in Treating Diabetes
LeRoith, D., & Vinik, A. I. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-572-5 · Cited by 11
Ruderman, N. B., & Shulman, G. I. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00044-7 · Cited by 7
Obesidad abdominal, resistencia a la insulina y riesgo metabólico y vascular
Ascaso, J. F. (2008) · Medicina Clínica · doi:10.1016/s0025-7753(08)72287-5 · Cited by 7
Association of Parity With Insulin Resistance Early in Pregnant Women: ECLIPSES Study
Motevalizadeh, E., Díaz‐López, A., Martín‐Luján, F., Basora, J., & Arija, V. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad594 · Cited by 7
Raza, I., Hassan, N., Gul, P., Jafri, A., Zehra, N., & Younas, N. (2015) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2016/20530 · Cited by 6
Resistencia a la insulina, obesidad y síndrome metabólico en el síndrome del ovario poliquístico
Gambineri, A., & Pasquali, R. (2006) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(06)71168-8 · Cited by 6
Evaluation of Metabolic Syndrome and Vitamin D Receptor Gene Polymorphism in Male Factor Infertility
Bhakat, R., Chandra, L., Saxena, A., Sarda, A. K., Krishnamurthy, K., & Yadav, P. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0632-y · Cited by 6
Ruderman, N. B., & Shulman, G. I. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00043-3 · Cited by 7
Hsieh, C., Hung, Y., Wu, D., Kuo, S., Lee, C.-H., Sheu, W. H., Li, J.-C., Yeh, K.-H., Chen, C., & Pei, D. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.1.74 · Cited by 6
Metabolic Syndrome and Ethnicity
Tillin, T., & Forouhi, N. G. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch2 · Cited by 6
Lee, J. H., Park, H. K., Kwon, M., Ham, S., Gil, H., Lim, S.-Y., & Song, J. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01042-9 · Cited by 5
Estimation of the disposition index based on components of metabolic syndrome
Lin, J., Hsieh, C. H., Liu, C. C., Lian, W., Wu, C., Hsu, C., Pei, D., Hsia, T., & Chen, Y. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej13-0510 · Cited by 5
[The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease].
Kozłowska, A., & Kowalska, I. (2006) · PubMed · Cited by 5
Gomes, F. A., Magalhães, P. V. D. S., Kunz, M., da Silveira, L. E., Weyne, F., Andreazza, A. C., Ceresér, K. M., Furlanetto, T. W., & Kapczinski, F. P. (2010) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832010000200009 · Cited by 5
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-20797-1_34-2 · Cited by 5
Chronomics of the Metabolic Syndrome
HANSEN, B. C. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_19 · Cited by 5
Identifying Subjects with Insulin Resistance by Using the Modified Criteria of Metabolic Syndrome
Hsieh, C., Pei, D., Hung, Y.-J., Kuo, S., He, C.-T., Lee, C., & Wu, C. (2008) · Journal of Korean Medical Science · doi:10.3346/jkms.2008.23.3.465 · Cited by 5
Bays, H. E., Varney, C., Alexander, L., Ng, J., Tondt, J., Weber, C., Christensen, S. M., Burridge, K., Brown, C., Bindlish, S., et al. (2026) · Obesity Pillars · doi:10.1016/j.obpill.2026.100283 · Cited by 4
Vascular biomarkers in the metabolic syndrome
Thande, N. K., & Rosenson, R. S. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.2 · Cited by 4
Prakaschandra, R., & Naidoo, D. P. (2022) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2022.102524 · Cited by 4
The Metabolic Syndrome: Time for a Critical Appraisal
Kahn, R., Buse, J. B., Ferrannini, E., & Stern, M. P. (2006) · Arterial’naya Gipertenziya (Arterial Hypertension) · doi:10.18705/1607-419x-2006-12-2-99-116 · Cited by 5
Effect of body mass index on diabetogenesis factors at a fixed fasting plasma glucose level
Lin, J.-D., Hsu, C., Wu, C., Hsieh, A., Hsieh, C., Liang, Y.-J., Chen, Y., Pei, D., & Chang, J.-B. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189115 · Cited by 4
Eglit, T. (2014) · DSpace repository (University of Tartu) · Cited by 4
Temas de actualidad en cardiología preventiva: el síndrome metabólico
Ligorit, A. D. R., Montero, I. J. F., Casasnovas, J. A., Ezquerra, E. A., Laclaustra, M., León, M., Cordero, A., & Grima, A. (2005) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(05)74097-8 · Cited by 3
Esteghamati, A., Zandieh, A., Zandieh, B., Khalilzadeh, O., Esteghamati, S., Meysamie, A., & Nakhjavani, M. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0002 · Cited by 3
Okosun, I. S., Boltri, J. M., Davis‐Smith, M., & Ndirangu, M. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.07.006 · Cited by 3
Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
Khan, S. H., Khan, F. A., Ijaz, A., Sattar, A., Dilawar, M., & Hashim, R. (2008) · PubMed · Cited by 3
Effect of Exercise Training on Metabolic Syndrome z-score : the Association of C- reactive protein
Gates, T. (2015) · The Scholarship East Carolina University's Institutional Repository (East Carolina University) · Cited by 3
Pasquali, R., & Gambineri, A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-310-3_30 · Cited by 3
Role of Obesity and Adiposity in PCOS
Pasquali, R., Patton, L., Diamanti‐Kandarakis, E., & Gambineri, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-69248-7_6 · Cited by 3
Advanced glycation end products and breast cancer risk in a sample of the ORDET cohort
Agnoli, C., Perlino, F. L., Guerra, G., Quartiroli, M., Vener, C., Mauri, P., Palma, A. D., Venturelli, E., & Sieri, S. (2025) · The International Journal of Biological Markers · doi:10.1177/03936155241309927 · Cited by 2
Viso, M., Porrello, B., Rauseo, D., Reverón, D., Rivas, B., Galdona, E., Rodriguez, L., Rodríguez, Z., Fernández, Y., de León, A. C., et al. (2013) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 2
Metabolic syndrome of prediabetic and diabetic subjects in a Bangladeshi population
Hossain, M., Kabir, G., Hasan, N., Faruque, O. M., Sikdar, D., Alauddin, M., & Ali, L. (2009) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2009.04.007 · Cited by 2
Longo‐Mbenza, B., Mvindu, H. N., Phanzu, B. K., On'kin, J. B. K. L., Bikuku, H. N., & Okwe, A. N. (2010) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2010.01.003 · Cited by 2
Vigil, L., Goday, A., Gabriel, R., Ascaso, J. F., Franch‐Nadal, J., & Ortega, R. (2011) · International Journal of Clinical Medicine · doi:10.4236/ijcm.2011.24063 · Cited by 2
Síndrome metabólico: ¿Queda espacio para este concepto?
Rivas, G., & Pablo, J. (2012) · Revista Venezolana de Endocrinología y Metabolismo · Cited by 2
Lin, J., Hsieh, C. H., Lian, W., Pei, D., Liang, Y., & Chen, Y. (2016) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2016.203 · Cited by 2
Gill, R. M., Jackson, R. T., Duane, M., Miner, A., & Khan, S. A. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14080881 · Cited by 2
Hipertensión arterial y síndrome metabólico
Fort, A. C., Arribas, J. M., & Ezquerra, E. A. (2006) · Hipertensión · doi:10.1016/s0212-8241(06)71715-7 · Cited by 2
Mohan, G., Dhir, T., & Chandey, M. (2019) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20193261 · Cited by 2
Mechanisms and Treatment of Obesity in Polycystic Ovary Syndrome
Pasquali, R., & Gambineri, A. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-108-6_14 · Cited by 2
Ocena stężenia wybranych adipocytokin u chorych z zespołem metabolicznym i nadciśnieniem tętniczym
Foremska-Iciek, J. (2010) · Biblioteka Uniwersytetu Medycznego w Poznaniu · Cited by 1
Insulinorresistencia, obesidad y síndrome metabólico. Cohorte CDC de Canarias en Venezuela
Viso, M., Rodríguez, Z., Aponte, L., Carmiol, A. M., Barreto, P., de León, A. C., Fernández, Y., Galdona, E., Reigosa, A., & Callegari, C. C. (2013) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 1
TNF Antagonists, The Prevention of Myocardial Infarction in Rheumatoid Arthritis Patients?
Yeo, L. T. (2013) · Res Medica · doi:10.2218/resmedica.v21i1.185 · Cited by 1
Phanzu, B. K., Longo‐Mbenza, B., On'kin, J. B. K. L., Pukuta, J. M., Vita, E. K., & Kianu, N. M. M. (2014) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2014.413076 · Cited by 1
Meigs, J. B. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-572-5_3 · Cited by 1
Himani, K., Gupta, V., Vandana, G., Mishra, S., & Mishra, S. (2017) · International Journal of Recent Scientific Research · doi:10.24327/ijrsr.2017.0803.0093 · Cited by 1
Purkait, P. (2020) · Diabetes & Obesity International Journal · doi:10.23880/doij-16000224 · Cited by 1
A New Predictor for Insulin Resistance in Polycystic Ovary Syndrome: InsuTAG
Omma, T., Gökçe, A., Çelik, M., Karahan, İ., Çulha, C., & Gülçelik, N. E. (2023) · Current Women s Health Reviews · doi:10.2174/1573404820666230301115706 · Cited by 1
Bilici (2011) · AFRICAN JOURNAL OF BIOTECHNOLOGY · doi:10.5897/ajb11.3291 · Cited by 1
Chicco, A. G. (2018) · FABICIB · doi:10.14409/fabicib.v21i0.6869 · Cited by 1
Metabolic syndrome and kidney disease
Kramer, H., & Joshi, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00028-8 · Cited by 1
Association between risk factors of metabolic syndrome with lung function
Ahmed, M. S., Amberina, A. R., Rehman, A., & Mirza, U. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.5691 · Cited by 1
Lipoprotein-associated phospholipase A2 (Lp-PLA2) Impact and role as cardiovascular risk marker
Persson, M. (2008) · Lund University Publications (Lund University) · Cited by 1
Hipertensión arterial y síndrome metabólico
Fort, A. C., Arribas, J. M., & Ezquerra, E. A. (2006) · Hipertensión y Riesgo Vascular · doi:10.1016/s1889-1837(06)71590-2 · Cited by 1
Mediterranean Diet and the Metabolic Syndrome: The Role of Protein
Papakonstantinou, E., Panagiotakos, D. B., & Zampelas, A. (2005) · Current Nutrition & Food Science · doi:10.2174/157340105774574848 · Cited by 1
Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease
Ford, E. S., & Liu, S. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-116-5_5
Self-citationPasquali, R., & Gambineri, A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-250-6_4
Metabolic syndrome; treatment of hypertensive patients with this syndrome
Israili, Z. H., Lyoussi, B., Hernández-Hernández, R., & Velasco, M. (2006) · Redalyc (Universidad Autónoma del Estado de México)
Diabetes ¿Un concepto enfocado en reducción de riesgo cardiovascular?
Gonzalez-Rivas, J. P. (2013) · Actualidad Contable FACES
Optimal Adiposity Measurement and Risk Stratification in Established Ischaemic Stroke
Lennon, O., & Blake, C. (2014) · World Journal of Cardiovascular Diseases · doi:10.4236/wjcd.2014.413077
Síndrome metabólico, enfermedad cardiovascular y medicina sexual
Navarro, N. C. (2008) · Revista Internacional de Andrología · doi:10.1016/s1698-031x(08)72568-8
The health consequences in African–Americans of each componentof the metabolic syndrome
Sumner, A. E. (2006) · Future Lipidology · doi:10.2217/17460875.1.3.283
Inflammation, insulin resistance, and cardiovascular disease: Cause or correlate?
Sattar, N. A. (2008) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-008-0011-6
Nonalcoholic Fatty Liver Disease and Extra-hepatic Malignancy
Albert, D. M., & Torres, D. M. (2014) · Current Hepatology Reports · doi:10.1007/s11901-014-0213-y
Lombardo, Y. B., Oliva, M. E., Selenscig, D. A., & Chicco, A. G. (2011) · Nuts and Seeds in Health and Disease Prevention · doi:10.1016/b978-0-12-375688-6.10125-2
Résistance à l’insuline et alimentation
Makoundou, V., & Golay, A. (2007) · Obésité · doi:10.1007/s11690-007-0074-4
Hyatt, M. A., Davidson, N. J., Sebert, S. P., Chan, L. L. Y., Stephenson, T. J., Symonds, M. E., Gardner, D. S., & Budge, H. (2008) · Proceedings of The Nutrition Society · doi:10.1017/s0029665108000773
Alternate Approaches To Managing Lipid-Associated Cardiovascular Risk
Hsia, S. H. (2007) · Future Lipidology · doi:10.2217/17460875.2.2.157
Prakaschandra, R. (2013) · ResearchSpace (University of KwaZulu-Natal)
Vascular risk factors and adipocyte dysfunction in metabolic syndrome
Hajer, G. R. (2008) · Utrecht University Repository (Utrecht University)
Relación entre ácido úrico y estrés oxidativo en pacientes con síndrome metabólico
Martínez, A. M. G., & Benavides, C. A. P. (2008) · Repositorio Institucional (Pontificia Universidad Javeriana)
CONTROVERSIES IN CARDIOVASCULAR MEDICINE
Kahn, R. (2007)
Insulin Dynamic Measures and Weight Change
Kloc, N. (2022) · Digital Archive @ GSU · doi:10.57709/7947965
González, J. R. G., & Madrigal, J. M. C. (2009) · Medicina Interna de México
The Relationship between Metabolic Syndrome and Pulmonary Function Original Article
Bae, M.-S., Han, J. H., Kim, J.-H., Kim, Y.-J., Lee, K.-J., & Kwon, K.-Y. (2016)
Preclinical atherosclerosis in rheumatoid arthritis
O’Sullivan, M. (2014) · Arrow@dit (Dublin Institute of Technology)
India, S., Phanikrishna, S. B. B., & Rao, E. V. (2014)
[From "deadly quartet" to "metabolic syndrome". An analysis of its clinical relevance].
Vancheri, F., Burgio, A., & Dovico, R. (2007) · PubMed
de Endocrinología, R. A., Bonneau, G. A., Rascón, C., & Susana, M. (2006)
Metabolic Syndrome and Type 2 Diabetes Mellitus
Jawa, A., & Fonseca, V. A. (2006) · CRC Press eBooks · doi:10.3109/9781420020601-4 · Cited by 1
Overview of insulin resistance and the metabolic syndrome
Sattar, N. A., & Mukhopadhyay, B. (2003) · CRC Press eBooks · doi:10.3109/9780203481165-13
The influence of age and nutrients on insulin sensitivity
Chee, C. (2016) · Nottingham ePrints (University of Nottingham)
García, C. (2016) · UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) · doi:10.35376/10324/20827
Uncovering Allostery in a Uniquely Folded Metalloprotein
Baxter, E. L. (2013) · eScholarship (California Digital Library)
Contreras, P. H., Bernal, Y. A., & Vigil, P. (2020) · Revista médica de Chile · doi:10.4067/s0034-98872020000400436
Csép, K. (2008) · Acta Endocrinologica (Bucharest) · doi:10.4183/aeb.2008.263
The Cardiovascular Consequences of Type 2 Diabetes Mellitus
Golden, S. H. (2009) · Humana Press eBooks · doi:10.1007/978-1-59745-260-1_5
Insulin Resistance and the Metabolic Syndrome
Banerji, M. A., Lam, M. L., & Chaiken, R. L. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_34
Metadata
- Authors
- Cheal, K. L., Abbasi, F., Lamendola, C., McLaughlin, T., Reaven, G. M., & Ford, E. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Stanford Medicine (US)
- Centers for Disease Control and Prevention (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2004-05-01
- Volume
- 53
- Issue
- 5
- Pages
- 1195-1200
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2018346950
- Cited by
- 312
- References
- 41
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 5 · 2023: 3 · 2022: 6 · 2021: 2 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 5 · 2016: 7 · 2015: 6 · 2014: 19 · 2013: 15 · 2012: 15
- FWCI
- 23.56
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- metabolic syndrome, insulin resistance, Adult Treatment Panel III criteria, diagnostic sensitivity, positive predictive value, steady-state plasma glucose, triglycerides, HDL cholesterol, blood pressure, obesity, cardiovascular risk
- MeSH terms
- Adult, Aged, Blood Glucose, Blood Pressure, Body Weight, Diagnostic Tests, Routine, Female, Homeostasis, Humans, Insulin Resistance, Cholesterol, HDL, Male, Middle Aged, Osmolar Concentration, Predictive Value of Tests, Sensitivity and Specificity, Triglycerides, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review